Arvind Utchanah
Director of Finance/CFO at KNIGHT THERAPEUTICS INC.
Net worth: 153 413 $ as of 2024-03-30
Profile
Arvind Utchanah is currently the Chief Financial Officer at Knight Therapeutics, Inc. He previously worked as the Director-Finance, Accounting & Financial Planning at Paladin Labs, Inc. from 2012 to 2016.
Mr. Utchanah has an undergraduate degree from McGill University and a graduate degree from Concordia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-11 | 39,136 ( 0.04% ) | 153 413 $ | 2024-03-30 |
Arvind Utchanah active positions
| Companies | Position | Start |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Director of Finance/CFO | 2020-03-29 |
Former positions of Arvind Utchanah
| Companies | Position | End |
|---|---|---|
| PALADIN LABS INC. | Director of Finance/CFO | 2016-05-31 |
Training of Arvind Utchanah
| McGill University | Undergraduate Degree |
| Concordia University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Arvind Utchanah
